GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Searle Co Ltd (KAR:SEARL) » Definitions » EBITDA Margin %

The Searle Co (KAR:SEARL) EBITDA Margin % : 18.59% (As of Dec. 2024)


View and export this data going back to 1993. Start your Free Trial

What is The Searle Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. The Searle Co's EBITDA for the three months ended in Dec. 2024 was ₨1,370 Mil. The Searle Co's Revenue for the three months ended in Dec. 2024 was ₨7,371 Mil. Therefore, The Searle Co's EBITDA margin for the quarter that ended in Dec. 2024 was 18.59%.


The Searle Co EBITDA Margin % Historical Data

The historical data trend for The Searle Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Searle Co EBITDA Margin % Chart

The Searle Co Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.67 26.61 21.41 16.10 19.43

The Searle Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.30 7.90 374.07 19.79 18.59

Competitive Comparison of The Searle Co's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, The Searle Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Searle Co's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The Searle Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where The Searle Co's EBITDA Margin % falls into.


;
;

The Searle Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

The Searle Co's EBITDA Margin % for the fiscal year that ended in Jun. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2024 )/Revenue (A: Jun. 2024 )
=5712.078/29400.675
=19.43 %

The Searle Co's EBITDA Margin % for the quarter that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=1369.932/7370.678
=18.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Searle Co  (KAR:SEARL) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


The Searle Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of The Searle Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


The Searle Co Business Description

Traded in Other Exchanges
N/A
Address
Tipu Sultan Road, Plot No. 1, One IBL Centre, 2nd Floor, Block 7 and 8, D.M.C.H.S, Off Shahra-e-Faisal, Karachi, SD, PAK, 75530
The Searle Co Ltd is a pharmaceutical company. It is principally engaged in the manufacture of pharmaceutical and other consumer products. The company manufactures pharmaceutical products like Hydryllin, Extor, Nuberol, Forte, Peditral, Selanz SR, Tramal, and other products. Its pharmaceutical product range covers the therapeutic areas of cardiovascular, antibiotics, nutrition, respiratory care, gastroenterology, oncology, hepatology, neurology and psychiatry, probiotics, antibiotics, and nutritional care.

The Searle Co Headlines

No Headlines